Systemic inflammation and prognosis in patients with <scp> RAS </scp> / <scp> BRAF </scp> wild‐type metastatic colorectal cancer receiving anti‐ <scp>EGFR</scp> therapy: A real‐world cohort study

Jordan W. Appleyard, Faye Elliott, Nancy L. Sapanara, Liping Zhang, Uday Kurkure, Jenny F. Seligmann, Nicholas P. West, Kandavel Shanmugam, Philip Quirke, Christopher J. M. Williams, Unknown

Open source

DOI: 10.1111/codi.70639
Published: 2026-09-25
Container: Colorectal Disease
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/codi.70639,
  title = {Systemic inflammation and prognosis in patients with
                    <scp>
                      <i>RAS</i>
                    </scp>
                    /
                    <scp>
                      <i>BRAF</i>
                    </scp>
                    wild‐type metastatic colorectal cancer receiving anti‐
                    <scp>EGFR</scp>
                    therapy: A real‐world cohort study},
  author = {Jordan W. Appleyard and Faye Elliott and Nancy L. Sapanara and Liping Zhang and Uday Kurkure and Jenny F. Seligmann and Nicholas P. West and Kandavel Shanmugam and Philip Quirke and Christopher J. M. Williams and Unknown},
  year = {2026},
  journal = {Colorectal Disease},
  doi = {10.1111/codi.70639},
  url = {https://doi.org/10.1111/codi.70639}
}

RIS

TY  - JOUR
TI  - Systemic inflammation and prognosis in patients with
                    <scp>
                      <i>RAS</i>
                    </scp>
                    /
                    <scp>
                      <i>BRAF</i>
                    </scp>
                    wild‐type metastatic colorectal cancer receiving anti‐
                    <scp>EGFR</scp>
                    therapy: A real‐world cohort study
AU  - Jordan W. Appleyard
AU  - Faye Elliott
AU  - Nancy L. Sapanara
AU  - Liping Zhang
AU  - Uday Kurkure
AU  - Jenny F. Seligmann
AU  - Nicholas P. West
AU  - Kandavel Shanmugam
AU  - Philip Quirke
AU  - Christopher J. M. Williams
AU  - Unknown
PY  - 2026
JO  - Colorectal Disease
DO  - 10.1111/codi.70639
UR  - https://doi.org/10.1111/codi.70639
ER  -

APA

Appleyard, J. W., Elliott, F., Sapanara, N. L., Zhang, L., Kurkure, U., Seligmann, J. F., West, N. P., Shanmugam, K., Quirke, P., Williams, C. J. M., & Unknown (2026). Systemic inflammation and prognosis in patients with <scp> RAS </scp> / <scp> BRAF </scp> wild‐type metastatic colorectal cancer receiving anti‐ <scp>EGFR</scp> therapy: A real‐world cohort study. Colorectal Disease. https://doi.org/10.1111/codi.70639

Source records

crossref · retrieved 2026-09-26T17:47:07.030Z

Systemic inflammation and prognosis in patients with <scp> <i>RAS</i> </scp> / <scp> <i>BRAF</i> </scp> wild‐type metastatic colorectal cancer receiving anti‐ <scp>EGFR</scp> therapy: A real‐world cohort study

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records